| Literature DB >> 20855299 |
Pamela M Vacek1, Dave K Verma, William G Graham, Peter W Callas, Graham W Gibbs.
Abstract
OBJECTIVES: To assess mortality in Vermont granite workers and examine relationships between silica exposure and mortality from lung cancer, kidney cancer, non-malignant kidney disease, silicosis and other non-malignant respiratory disease. Methods Workers employed between 1947 and 1998 were identified. Exposures were estimated using a job-exposure matrix. Mortality was assessed through 2004 and standardised mortality ratios (SMRs) were computed. Associations between mortality and exposure to silica were assessed by nested case-control analyses using conditional logistic regression. Results 7052 workers had sufficient data for statistical analysis. SMRs were significantly elevated for lung cancer (SMR 1.37, 95% CI 1.23 to 1.52), silicosis (SMR 59.13, 95% CI 44.55 to 76.97), tuberculosis (SMR 21.74, 95% CI 18.37 to 25.56) and other non-malignant respiratory disease (SMR 1.74, 95% CI 1.50 to 2.02) but not for kidney cancer or non-malignant kidney disease. In nested case-control analyses, significant associations with cumulative exposure to respirable free silica were observed for silicosis (OR 1.13, 95% CI 1.05 to 1.21 for each 1 mg/m(3)-year increase in cumulative exposure) and other non-malignant respiratory disease (OR 1.10, 95% CI 1.03 to 1.16) but not for lung cancer (OR 0.99, 95% CI 0.94 to 1.03), kidney cancer (OR 0.96, 95% CI 0.84 to 1.09) or non-malignant kidney disease (OR 0.95, 95% CI 0.84 to 1.08). Conclusions Exposure to crystalline silica in Vermont granite workers was associated with increased mortality from silicosis and other non-malignant respiratory disease, but there was no evidence that increased lung cancer mortality in the cohort was due to exposure. Mortality from malignant and non-malignant kidney disease was not significantly increased or associated with exposure.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20855299 PMCID: PMC3088478 DOI: 10.1136/oem.2009.054452
Source DB: PubMed Journal: Occup Environ Med ISSN: 1351-0711 Impact factor: 4.402
Estimated exposure concentrations of respirable free silica by time period
| Job class | Location | <1940 | 1940–1949 | ≥1950 | ||
| N | mg/m3 | mg/m3 | N | mg/m3 | ||
| Bit grinder | Quarry | 1 | 0.17 | |||
| Blacksmith | Quarry | 4 | 0.03 | |||
| Boxer | Shed | 14 | 0.08 | 0.06 | 103 | 0.04 |
| Carver | Shed | 19 | 0.37 | 0.22 | 149 | 0.07 |
| Channel bar | Quarry | 3 | 0.15 | 0.08 | 0.01 | |
| Crane | Shed | 9 | 0.16 | 0.11 | 32 | 0.05 |
| Cutter | Shed | 331 | 0.39 | 0.23 | 1569 | 0.07 |
| Draftsman | Shed | 12 | 0.01 | 0.01 | 0.01 | |
| Driller | Quarry | 120 | 1.07 | 0.54 | 7 | 0.01 |
| Foreman | Shed | 0.12 | 0.09 | 9 | 0.05 | |
| Grinder | Shed | 31 | 0.19 | 0.13 | 5 | 0.07 |
| Jackhammer | Quarry | 10 | 1.05 | 0.56 | 7 | 0.06 |
| Labourer | Shed | 0.24 | 0.17 | 8 | 0.10 | |
| Lumper | Shed | 5 | 0.30 | 0.18 | 138 | 0.06 |
| Maintenance | Shed | 12 | 0.24 | 0.16 | 28 | 0.07 |
| Quarry (general) | Quarry | 22 | 0.13 | 0.07 | 0.01 | |
| Office worker | Shed | 29 | 0.04 | 0.04 | 0.04 | |
| Polisher | Shed | 35 | 0.12 | 0.10 | 570 | 0.07 |
| Sandblaster | Shed | 43 | 0.24 | 0.16 | 337 | 0.07 |
| Sawyer | Shed | 13 | 0.13 | 0.10 | 634 | 0.06 |
| Shed (general) | Shed | 153 | 0.12 | 0.09 | 491 | 0.05 |
| Surfacer | Shed | 150 | 0.28 | 0.18 | 101 | 0.08 |
Estimates are averages of those for the earlier and later periods because few measurements were available from 1940 to 1949.
Job not performed after 1939.
Trend applied using jackhammer and driller data.
Characteristics of the final cohort
| N | % | |
| Date of birth | ||
| <1900 | 781 | 11.1 |
| 1900–1909 | 933 | 13.2 |
| 1910–1919 | 1003 | 14.2 |
| 1920–1929 | 1177 | 16.7 |
| 1930–1939 | 1093 | 15.5 |
| 1940–1949 | 997 | 14.1 |
| ≥1950 | 1068 | 15.1 |
| Date began employment | ||
| <1930 | 1170 | 16.6 |
| 1930–1939 | 544 | 7.7 |
| 1940–1949 | 1137 | 16.1 |
| 1950–1959 | 1350 | 19.1 |
| 1960–1969 | 1455 | 20.6 |
| ≥1970 | 1396 | 19.8 |
| Vital status through 31 December 2004 | ||
| Alive | 3133 | 44.4 |
| Deceased | 3845 | 54.5 |
| Unknown | 74 | 1.0 |
| Total | 7052 | |
Causes of death through 2004: SMRs and CIs based on US white male rates
| 95% Confidence limits | |||||
| Cause of death (ICD-9 codes) | Observed | Expected | SMR | Lower | Upper |
| Tuberculosis | 147 | 6.8 | 21.75 | 18.37 | 25.56 |
| All malignant neoplasms | 896 | 795.4 | 1.13 | 1.05 | 1.20 |
| Buccal cavity and pharynx | 20 | 19.9 | 1.01 | 0.62 | 1.55 |
| Digestive organs and peritoneum | 218 | 209.9 | 1.04 | 0.91 | 1.19 |
| Larynx | 10 | 10.1 | 0.99 | 0.48 | 1.82 |
| Bronchus, trachea, lung | 359 | 261.5 | 1.37 | 1.23 | 1.52 |
| Cancer of prostate | 61 | 68.5 | 0.89 | 0.68 | 1.14 |
| Kidney | 28 | 19.8 | 1.41 | 0.94 | 2.04 |
| Bladder and other urinary organs | 34 | 23.8 | 1.43 | 0.99 | 2.00 |
| All lymphatic, haematopoietic tissue | 73 | 78.8 | 0.93 | 0.73 | 1.16 |
| All other malignant neoplasms | 93 | 105.1 | 0.88 | 0.71 | 1.08 |
| Cerebrovascular disease | 217 | 213.0 | 1.02 | 0.89 | 1.16 |
| All heart disease | 1219 | 1372.4 | 0.89 | 0.84 | 0.94 |
| Non-malignant respiratory disease | 377 | 272.5 | 1.38 | 1.25 | 1.53 |
| Influenza and pneumonia | 71 | 88.1 | 0.81 | 0.63 | 1.02 |
| Bronchitis, emphysema, asthma | 77 | 81.6 | 0.94 | 0.75 | 1.18 |
| Silicosis | 55 | 0.9 | 59.13 | 44.55 | 76.97 |
| Other non-malignant respiratory disease | 174 | 100.0 | 1.74 | 1.50 | 2.02 |
| Diabetes mellitus | 67 | 61.2 | 1.09 | 0.85 | 1.39 |
| Cirrhosis of liver | 63 | 77.3 | 0.82 | 0.63 | 1.04 |
| Nephritis and nephrosis | 34 | 34.4 | 0.99 | 0.68 | 1.38 |
| All external causes of death | 264 | 304.7 | 0.87 | 0.77 | 0.98 |
| All other causes of death | 326 | 410.7 | 0.79 | 0.71 | 0.89 |
ICD-9, 9th Revision of the International Classification of Diseases; SMR, standardised mortality ratio.
Significant at the 5% level.
Significant at the 1% level.
Associations between lung cancer risk and exposure measured as continuous variables
| No lag | 10-Year lag | |||||||
| Coefficient | OR | 95% CI | p Value | Coefficient | OR | 95% CI | p Value | |
| All workers (356 cases, 941 controls) | ||||||||
| Cumulative exposure: 1 mg/m3-year | −0.0100 | 0.99 | 0.95 to 1.03 | 0.641 | −0.0120 | 0.99 | 0.94 to 1.03 | 0.598 |
| Log transformed cumulative exposure: 1 ln(mg/m3-years) | 0.0518 | 1.05 | 0.97 to 1.14 | 0.208 | 0.0319 | 1.03 | 0.96 to 1.11 | 0.388 |
| Net duration of employment: 10 years | 0.0123 | 1.01 | 0.93 to 1.10 | 0.771 | 0.0203 | 1.02 | 0.93 to 1.12 | 0.671 |
| Average exposure: 0.10 mg/m3 | −0.0207 | 0.98 | 0.83 to 1.16 | 0.809 | −0.0092 | 0.99 | 0.85 to 1.16 | 0.907 |
| Workers born before 1920 (189 cases, 497 controls) | ||||||||
| Cumulative exposure: 1 mg/m3-year | −0.0176 | 0.98 | 0.94 to 1.03 | 0.450 | −0.0182 | 0.98 | 0.94 to 1.03 | 0.444 |
| Log transformed cumulative exposure: 1 ln(mg/m3-years) | 0.0407 | 1.04 | 0.93 to 1.16 | 0.466 | 0.0246 | 1.03 | 0.94 to 1.12 | 0.591 |
| Net duration of employment: 10 years | −0.0648 | 0.94 | 0.84 to 1.05 | 0.266 | −0.0062 | 0.94 | 0.83 to 1.06 | 0.331 |
| Average exposure: 0.10 mg/m3 | −0.0159 | 0.98 | 0.82 to 1.18 | 0.860 | 0.0062 | 1.01 | 0.86 to 1.18 | 0.939 |
| Workers born in or after 1920 (167 cases, 444 controls) | ||||||||
| Cumulative exposure: 1 mg/m3-year | 0.0420 | 1.04 | 0.93 to 1.17 | 0.484 | 0.0838 | 1.09 | 0.91 to 1.30 | 0.362 |
| Log transformed cumulative exposure: 1 ln(mg/m3-years) | 0.0646 | 1.07 | 0.95 to 1.20 | 0.285 | 0.0433 | 1.04 | 0.93 to 1.17 | 0.456 |
| Net duration of employment: 10 years | 0.0962 | 1.10 | 0.98 to 1.24 | 0.114 | 0.1260 | 1.13 | 0.98 to 1.30 | 0.082 |
| Average exposure: 0.10 mg/m3 | −0.0566 | 0.95 | 0.58 to 1.54 | 0.821 | −0.2220 | 0.80 | 0.44 to 1.45 | 0.465 |
OR per specified units of increase in exposure.
Associations between categories of cumulative exposure and mortality from selected disease
| Trend test p value | ||||||
| Quintiles of cumulative exposure | Cases | Controls | OR | 95% CI | p Value | |
| Silicosis (55 cases) | ||||||
| ≤1.04 mg/m3 years | 4 | 40 | 1.00 | – | – | <0.001 |
| 1.05–3.64 mg/m3 years | 5 | 38 | 2.02 | 0.45 to 9.09 | 0.358 | |
| 3.65–6.71 mg/m3 years | 13 | 30 | 8.62 | 1.86 to 39.95 | 0.006 | |
| 6.72–10.21 mg/m3 years | 17 | 27 | 12.36 | 2.67 to 57.2 | 0.001 | |
| >10.21 mg/m3 years | 16 | 27 | 10.55 | 2.30 to 48.4 | 0.002 | |
| Other non-malignant respiratory disease (172 cases) | ||||||
| ≤0.36 mg/m3 years | 38 | 92 | 1.00 | – | – | 0.318 |
| 0.37–1.18 mg/m3 years | 28 | 97 | 0.67 | 0.37 to 1.19 | 0.170 | |
| 1.19–2.57 mg/m3 years | 31 | 94 | 0.76 | 0.43 to 1.33 | 0.331 | |
| 2.58–5.41 mg/m3 years | 28 | 99 | 0.68 | 0.37 to 1.25 | 0.271 | |
| >5.41 mg/m3 years | 47 | 79 | 1.39 | 0.76 to 2.54 | 0.279 | |
| Lung cancer (356 cases) | ||||||
| ≤0.26 mg/m3 years | 84 | 241 | 1.00 | — | — | 0.316 |
| 0.26–0.82 mg/m3 years | 56 | 176 | 0.87 | 0.56 to 1.29 | 0.481 | |
| 0.82–2.09 mg/m3 years | 91 | 206 | 1.28 | 0.90 to 1.83 | 0.170 | |
| 2.09–4.10 mg/m3 years | 74 | 167 | 1.29 | 0.87 to 1.89 | 0.202 | |
| > 4.10 mg/m3 years | 51 | 151 | 0.96 | 0.60 to 1.54 | 0.880 | |
| Kidney cancer (28 cases) | ||||||
| ≤0.49 mg/m3 years | 9 | 14 | 1.00 | – | – | 0.967 |
| 0.50–1.42 mg/m3 years | 3 | 19 | 0.22 | 0.05 to 1.07 | 0.061 | |
| 1.43–2.54 mg/m3 years | 2 | 20 | 0.49 | 0.16 to 1.52 | 0.217 | |
| 2.55–4.41 mg/m3 years | 7 | 16 | 1.68 | 0.37 to 7.69 | 0.505 | |
| >4.41 mg/m3 years | 7 | 15 | 0.90 | 0.20 to 3.97 | 0.886 | |
| Non-malignant kidney disease (32 cases) | ||||||
| ≤0.68 mg/m3 years | 7 | 18 | 1.00 | – | – | 0.919 |
| 0.69–1.66 mg/m3 years | 5 | 20 | 0.61 | 0.17 to 2.17 | 0.446 | |
| 1.67–3.19 mg/m3 years | 7 | 18 | 1.04 | 0.32 to 3.34 | 0.945 | |
| 3.20–6.01 mg/m3 years | 7 | 18 | 1.09 | 0.26 to 4.52 | 0.904 | |
| >6.01 mg/m3 years | 6 | 19 | 0.76 | 0.19 to 3.06 | 0.704 | |